PMID: 6168223Sep 1, 1981Paper

Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer

Annals of Internal Medicine
N J VogelzangB J Kennedy

Abstract

Raynaud's phenomenon occurred in 22 of 60 men (37%) treated with vinblastine and bleomycin with or without cisplatin for germ cell testicular cancer. An additional six patients (10%) had symptoms suggestive of Raynaud's phenomenon. Patients with and without Raynaud's phenomenon did not differ with respect to median age; tumor histology; total doses of vinblastine, bleomycin, and cisplatin; or the frequency of vinblastine-induced neuropathy and bleomycin-induced cutaneous toxicity. Digital ischemia occurred in 21% of patients treated with only vinblastine and bleomycin, and in 41% of patients treated also with cisplatin. Cigarette smoking was commoner in patients with than in those without Raynaud's phenomenon. Hand arteriograms showed diffuse arterial narrowing and abrupt vascular cutoffs. Except for one patient with a very low titer of cold agglutinins, no patient had detectable antinuclear antibody, rheumatoid factor, cryoglobulins, or cold agglutinins. Raynaud's phenomenon is a common delayed toxicity after chemotherapy with vinblastine, bleomycin, and cisplatin in patients with germ cell neoplasms.

Citations

Mar 25, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M ReiserG Fätkenheuer
Jan 1, 1991·Archives of Toxicology·J HayG Laurent
Jun 1, 1993·Immunität und Infektion·E RötherH H Peter
Apr 19, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Christopher KimYawei Zhang
Dec 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C C BergerH J Schmoll
Apr 1, 1996·Critical Reviews in Oncology/hematology·S CulineJ P Droz
Sep 23, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Raghavan
Mar 16, 2011·Nature Reviews. Urology·Chunkit Fung, David J Vaughn
Jul 24, 1997·The New England Journal of Medicine·G J Bosl, R J Motzer
Feb 23, 2007·The New England Journal of Medicine·Donald S KaufmanShahin Tabatabaei
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cristina GervasoniMassimo Galli
Jun 30, 2010·Journal of the National Cancer Institute·Lois B TravisSophie D Fossa
Apr 17, 1999·Journal of Pediatric Hematology/oncology·G A HaleM M Hudson
Dec 3, 2011·American Journal of Clinical Oncology·Bradford S HoppeDaniel J Indelicato
Dec 9, 2008·The Cancer Journal·Kenneth D Miller, Laura R Triano
Mar 1, 1991·The Australian and New Zealand Journal of Surgery·G J Lindeman, K W Tiver
Nov 1, 1990·Annals of the Rheumatic Diseases·C Tolosa-VilellaR Jordana-Comajuncosa
Apr 17, 2001·Annals of the Rheumatic Diseases·M Abu-ShakraY Shoenfeld
Apr 14, 1990·BMJ : British Medical Journal·I W GarstinJ M Hood
Mar 1, 1990·Postgraduate Medical Journal·A PagliucaG J Mufti
Jul 5, 2011·Arthritis Research & Therapy·Katarzyna Elandt, Daniel Aletaha
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mette SprautenLois B Travis
Jul 31, 2003·Drugs·Uzair B Chaudhary, Jason R Haldas
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·P W van BarneveldR Peset
Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·J van der MeerJ G Aalders
Jan 1, 1990·Cancer Investigation·J BellmuntL Jolis
Feb 1, 1987·International Journal of Andrology·G J BoslE Scheiner
Feb 1, 1987·International Journal of Andrology·B L SamuelsB J Kennedy
Oct 1, 1991·European Journal of Vascular Surgery·P VowdenR C Kester
Dec 18, 2013·Seminars in Oncology·Roderick SkinnerPaul C Nathan
Nov 23, 2005·Urologic Oncology·Robert AbouassalyDerek Raghavan
Sep 13, 2011·Critical Reviews in Oncology/hematology·Andreas A ArgyriouGuido Cavaletti
Jan 1, 1994·Scandinavian Journal of Rheumatology·M Raderer, W Scheithauer
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald de Wit
Nov 23, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Janine NuverJourik A Gietema
Nov 23, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard Steingart
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carvell T NguyenAndrew J Stephenson
Sep 5, 1998·The Urologic Clinics of North America·G D Grossfeld, E J Small
Feb 14, 2006·Seminars in Oncology·Nasir ShahabDonald C Doll
Oct 1, 1993·Clinics in Dermatology·N Mobini, A R Ahmed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.